Amundi Has $521,000 Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Amundi lifted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 199.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,954 shares of the company’s stock after purchasing an additional 27,288 shares during the period. Amundi’s holdings in Pediatrix Medical Group were worth $521,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of MD. State Street Corp increased its position in shares of Pediatrix Medical Group by 1.4% during the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after acquiring an additional 50,597 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Pediatrix Medical Group by 51.6% in the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock valued at $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC raised its position in shares of Pediatrix Medical Group by 302.9% in the third quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after purchasing an additional 106,817 shares during the period. Franklin Resources Inc. bought a new position in shares of Pediatrix Medical Group in the third quarter valued at about $598,000. Finally, Principal Financial Group Inc. increased its position in Pediatrix Medical Group by 14.1% during the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after acquiring an additional 63,581 shares during the period. 97.71% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on MD. Macquarie initiated coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group upped their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $14.12 on Friday. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The stock’s 50 day moving average is $14.28 and its 200-day moving average is $13.49. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.76, a PEG ratio of 1.74 and a beta of 1.49.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.